STOCK TITAN

Q2 Holdings Inc Form 4 Filings

QTWO NYSE

Every Form 4 that Q2 Holdings Inc (QTWO) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow QTWO and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QTWO filings page.

Rhea-AI Summary

Q2 Holdings, Inc. (QTWO) reported that its General Counsel, Michael S. Kerr, had 636 shares of common stock sold on September 11, 2026 at $60.96 per share. According to the company, this issuer-mandated sale was executed solely to cover tax withholding on vested Restricted Stock Units and was not a discretionary trade. After this transaction, Kerr directly holds 80,739 shares of Q2 Holdings common stock, with no Rule 10b5-1 trading plan reported.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Financial Officer Jonathan Price reported a sale of 77,180 shares of common stock on August 13, 2026. The shares were sold at a weighted average price of $65.71 per share, in multiple trades between $65.00 and $66.27. Following this planned sale under a Rule 10b5-1 trading plan adopted on September 2, 2025, Price directly holds 207,633 shares of Q2 Holdings common stock.

Rhea-AI Summary

Q2 Holdings, Inc. Chief People Officer Kimberly Anne Rutledge reported a sale of 10,000 shares of Common Stock on August 10, 2026 at a weighted average price of $63.07 per share. The shares were sold in multiple transactions at prices ranging from $62.09 to $63.46, and Rutledge now holds 113,913 shares directly. The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on May 9, 2026.

Rhea-AI Summary

Q2 Holdings, Inc. reported that director Stephen C. Hooley acquired 4,741 shares of common stock through a grant of Restricted Stock Units. These units were awarded at no cash cost and increase his direct holdings to 25,523 shares. The Restricted Stock Units will vest in equal quarterly installments over one year beginning on September 3, 2026, meaning the shares become fully owned gradually over that period as service conditions are met.

Rhea-AI Summary

Tyson Lynn Antipas reported acquisition or exercise transactions in this Form 4 filing.

Q2 Holdings, Inc. director Tyson Lynn Antipas reported an equity compensation grant of restricted stock units tied to the company’s common stock. The award covers 4,741 shares at no purchase price and increases his direct holdings to 18,741 shares after the transaction.

The restricted stock units will vest in equal quarterly installments over one year, beginning on September 3, 2026. This reflects a standard director compensation grant rather than an open‑market purchase or sale.

Rhea-AI Summary

Mintz Andre L reported acquisition or exercise transactions in this Form 4 filing.

Q2 Holdings director Andre L. Mintz received a grant of 4,741 shares of common stock in the form of Restricted Stock Units. These RSUs vest in equal quarterly installments over one year beginning on September 3, 2026. Following this award, Mintz directly holds 7,676 shares of Q2 Holdings common stock.

Rhea-AI Summary

TAYLOR MARGARET reported acquisition or exercise transactions in this Form 4 filing.

Q2 Holdings, Inc. director Margaret Taylor reported receiving a grant of 4,741 shares of common stock in the form of Restricted Stock Units, with no cash paid per share. These RSUs vest in equal quarterly installments over one year beginning on September 3, 2026.

After this award, Taylor directly holds 25,727 shares of Q2 Holdings common stock. This is a routine, compensation-related equity grant rather than an open-market purchase or sale.

Rhea-AI Summary

Q2 Holdings, Inc. director James Offerdahl reported an acquisition of 4,741 shares of Common Stock through a grant of Restricted Stock Units. The units were awarded at no cash cost per share.

The Restricted Stock Units vest in equal quarterly installments over one year beginning on September 3, 2026. Following this award, Offerdahl directly holds 21,739 shares of Q2 Holdings common stock.

Rhea-AI Summary

Atchison Rebecca Lynn reported acquisition or exercise transactions in this Form 4 filing.

Q2 Holdings director Rebecca Lynn Atchison received an equity grant of 4,741 shares of common stock in the form of Restricted Stock Units (RSUs). The grant was reported at a price of $0.00 per share, indicating it is a compensation-related award rather than an open-market purchase.

After this award, Atchison directly holds 26,981 shares of Q2 Holdings common stock. According to the footnote, these RSUs will vest in equal quarterly installments over one year beginning on September 3, 2026, meaning the shares are earned gradually over four vesting dates.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Business Officer Kirk L. Coleman reported a mandated sale of 3,603 shares of common stock. The shares were sold on the open market at a weighted average price of $43.48 per share to cover tax withholding obligations tied to the vesting and settlement of Restricted Stock Units, so this was not a discretionary trade. After the transaction, he continues to hold 329,658 shares of Q2 Holdings common stock directly.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Business Officer Kirk L. Coleman reported a mix of equity awards and a mandated share sale. On 2026-06-01, he received two grants of common stock totaling 34,895 shares (17,934 shares and 16,961 shares) at no cost, reflecting above-target vesting of performance-based restricted stock units granted on May 31, 2023.

On the same date, 20,894 shares of common stock were sold at $49.50 per share to cover tax withholding obligations related to restricted stock unit vesting, which the footnote states was an issuer-mandated, non-discretionary sale. Following these transactions, Coleman directly holds 333,261 shares of Q2 Holdings common stock.

Rhea-AI Summary

Q2 Holdings, Inc. General Counsel Michael S. Kerr reported an issuer-mandated sale of 397 shares of common stock at $44.98 per share to cover tax withholding obligations tied to vesting Restricted Stock Units. After this non-discretionary sale, he directly holds 81,375 shares.

Rhea-AI Summary

Q2 Holdings, Inc.’s General Counsel Michael S. Kerr reported both a small stock sale and sizable equity awards. On March 11, 2026, he sold 2,071 shares of common stock in an open-market transaction at a weighted average price of $50.33, executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2025.

On the same date he received multiple stock grants, including time-based restricted stock units vesting 25% starting March 3, 2027 and quarterly thereafter for three years, and several types of performance-based restricted stock units tied to Adjusted EBITDA margin, subscription revenue growth, and relative stock price performance through the end of 2027 and beyond. After these transactions, he directly owned 81,772 shares of Q2 Holdings common stock.

Rhea-AI Summary

Mukkamala Himagiri K reported acquisition or exercise transactions in this Form 4 filing.

Q2 Holdings, Inc. Chief Operating Officer Mukkamala Himagiri K reported multiple equity grants of common stock as compensation. On March 11, 2026, he received an award of 38,544 restricted stock units that vest 25% starting March 3, 2027, with the balance vesting in equal quarterly installments over the following three years.

He also received three performance-based restricted stock unit awards of 15,418, 15,418, and 7,708 shares, each under the 2023 Equity Incentive Plan. These vest based on Q2’s attainment of Adjusted EBITDA margin, subscription revenue year-over-year growth, and stock price performance versus the S&P Software & Services Select Index over performance periods ending December 31, 2027, with vesting on the second or third anniversary of the grant date depending on results. Following these grants, he directly holds 169,998 shares of common stock.

Rhea-AI Summary

Flake Matthew P reported acquisition or exercise transactions in this Form 4 filing.

Q2 Holdings, Inc. Chief Executive Officer Matthew P. Flake received equity awards covering a total of 192,716 shares of common stock on March 11, 2026, reported at a grant price of $0.00 per share as compensation, not open‑market purchases.

The awards include time-based restricted stock units vesting 25% starting March 3, 2027, with the remainder vesting quarterly over three years, plus three performance-based RSU grants. These performance awards depend on Adjusted EBITDA margin, subscription revenue year-over-year growth, and stock performance versus the S&P Software & Services Select Index through periods ending in 2027. Following these grants, Flake directly holds 675,918 shares of Q2 common stock.

Rhea-AI Summary

Coleman Kirk L reported acquisition or exercise transactions in this Form 4 filing.

Q2 Holdings, Inc. reported that Chief Business Officer Kirk L. Coleman received equity awards of company common stock on March 11, 2026. He was granted a total of 67,452 shares at no cost, increasing his direct holdings to 319,260 shares after the transactions.

The awards consist of restricted stock units that vest over time and performance-based restricted stock units tied to adjusted EBITDA margin, subscription revenue year-over-year growth for the 12 months ending December 31, 2027, and Q2’s stock performance versus the S&P Software & Services Select Index, with vesting schedules running up to three years from grant.

Rhea-AI Summary

Price Jonathan reported acquisition or exercise transactions in this Form 4 filing.

Q2 Holdings Chief Financial Officer Jonathan Price reported multiple equity awards of Common Stock as compensation. On March 11, 2026, he received time-based restricted stock units and several performance-based restricted stock unit awards at a grant price of $0.00 per share. The time-based units vest 25% starting on March 3, 2027, with the rest vesting in equal quarterly installments over the following three years. Additional awards are tied to Q2’s Adjusted EBITDA margin, subscription revenue year-over-year growth, and relative stock performance versus the S&P Software & Services Select Index through December 31, 2027, with potential vesting from 0% up to 200% of target shares depending on results. Following these grants, Price directly holds 284,813 shares of Q2 common stock.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Delivery Officer John E. Breeden reported mixed insider activity in common stock. He sold 8,924 shares in an open-market transaction at a weighted average price of $50.34 per share under a pre-arranged Rule 10b5-1 trading plan adopted on May 19, 2025.

On the same date, he received several stock awards totaling multiple tranches of 28,908, 11,562, 11,562 and 5,784 shares at no cost, consisting of restricted stock units and performance-based restricted stock units under the 2023 Equity Incentive Plan. Following these transactions, he directly holds 133,128 shares.

The time-based restricted stock units vest 25% starting on March 3, 2027, then quarterly over three years. The performance-based units depend on Q2’s Adjusted EBITDA margin, subscription revenue year-over-year growth for the 12 months ending December 31, 2027, and relative stock performance versus the S&P Software & Services Select Index.

Rhea-AI Summary

Q2 Holdings, Inc. Chief People Officer Kimberly Anne Rutledge reported a mix of stock sales and equity awards. She sold 3,187 shares of common stock in an open-market transaction at a weighted average price of $50.37 per share, executed under a pre-arranged Rule 10b5-1 trading plan. After this sale, she continued to receive equity-based compensation, with multiple grants totaling 43,362 shares of restricted and performance-based stock units at no cash cost. These awards vest over multi-year schedules tied to time-based service and performance metrics, including Adjusted EBITDA margin, subscription revenue growth, and relative stock performance versus the S&P Software & Services Select Index. Following all reported transactions, Rutledge directly holds 123,913 shares of Q2 Holdings common stock, indicating the sale represents a small portion of her overall stake.

Rhea-AI Summary

Q2 Holdings, Inc.'s Chief Financial Officer Jonathan Price reported an issuer-mandated sale of 8,680 shares of common stock. The shares were sold on March 9, 2026 at a weighted average price of $51.35 per share, in multiple trades between $51.34 and $51.70.

The company required this sale to cover tax withholding obligations tied to the vesting and settlement of restricted stock units, so it was not a discretionary trade by the executive. After the transaction, Price directly holds 188,455 shares of Q2 Holdings common stock.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Business Officer Kirk L. Coleman reported an open-market sale of 10,849 shares of common stock at a weighted average price of $51.35 per share. According to the disclosure, this sale was mandated by the issuer solely to cover tax withholding obligations from vested restricted stock units and was not a discretionary trade. After the transaction, Coleman directly held 251,808 Q2 Holdings shares, indicating he retained a substantial equity position in the company.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Executive Officer Matthew P. Flake reported an open-market sale of 20,613 shares of common stock at a weighted average price of $51.35 per share. According to the disclosure, this was an issuer-mandated sale to cover tax withholding obligations tied to the vesting and settlement of restricted stock units, rather than a discretionary trade. After this transaction, Flake directly holds 483,202 shares of Q2 Holdings common stock.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Operating Officer Mukkamala Himagiri K reported an issuer-mandated sale of 1,343 shares of common stock on March 9, 2026. The shares were sold at a weighted average price of $51.35 per share to cover tax withholding on vested restricted stock units. After this transaction, he directly owns 92,910 shares of Q2 Holdings common stock. The company notes this was not a discretionary trade by the executive.

Rhea-AI Summary

Q2 Holdings, Inc. Chief People Officer Kimberly Anne Rutledge reported two open-market sales of Q2 common stock. On March 5, she sold 20,948 shares at a weighted average price of $51.66 per share, in multiple trades between $51.61 and $52.46. On March 9, she sold 4,340 shares at a weighted average price of $51.35 per share, in multiple trades between $51.34 and $51.70. The filing notes the activity was carried out under a Rule 10b5-1 trading plan adopted on September 12, 2025, and that the reported sale represents an issuer-mandated sale to cover tax withholding on vested restricted stock units, not a discretionary trade. Following these transactions, she directly held 83,738 Q2 common shares.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Delivery Officer John E. Breeden reported two open-market sales of common stock totaling 74,783 shares. On March 5, he sold 68,707 shares at a weighted average price of $51.73 per share, and on March 9, he sold 6,076 shares at a weighted average price of $51.35 per share. The prices reflect multiple trades within ranges of $50.63–$52.48 and $51.34–$51.70, respectively. These sales were effected under a Rule 10b5-l trading plan and represent issuer-mandated transactions to cover tax withholding on vested restricted stock units, not discretionary trades. Following the transactions, he held 84,236 shares of Q2 Holdings common stock directly.

Rhea-AI Summary

Q2 Holdings, Inc. general counsel Michael S. Kerr reported selling a total of 12,375 shares of common stock in two open-market transactions, at weighted average prices of about $51–52 per share. Following the most recent sale, he holds 47,227 shares directly.

The filing notes that one sale was executed under a Rule 10b5-1 trading plan adopted on September 11, 2025, and that another sale was mandated by the issuer to cover tax withholding obligations arising from the vesting and settlement of restricted stock units, rather than representing a discretionary trade.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Business Officer Kirk L. Coleman reported a mix of stock awards and sales. He acquired 23,556 and 21,746 shares of common stock at no cost from performance-based restricted stock units granted on March 2, 2023, after meeting vesting conditions tied to Adjusted EBITDA of Revenue and stock-price performance versus an industry index. To cover tax withholding on vested restricted stock units, he executed issuer-mandated open-market sales of 7,752 shares at $49.72 per share and 31,104 shares at $49.75 per share. Following these transactions, he directly holds 262,657 shares of Q2 Holdings common stock.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Operating Officer Mukkamala Himagiri K reported an issuer-mandated sale of 1,793 shares of common stock to cover tax withholding tied to vesting of restricted stock units. The weighted average sale price was about $49.75 per share, leaving him with 94,253 shares of directly held common stock.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Delivery Officer John E. Breeden reported a mix of stock awards and mandated sales. He received two grants of common stock totaling tens of thousands of shares at no cost upon vesting of performance-based restricted stock units tied to EBITDA and stock-price benchmarks. To cover tax withholding from these vestings, he sold 41,966 shares of common stock in open-market transactions at weighted-average prices around $49.7 per share. After these transactions, he directly owned 159,019 shares of Q2 Holdings common stock.

Rhea-AI Summary

Q2 Holdings, Inc. General Counsel Michael S. Kerr reported multiple stock transactions in company common shares. He received grants or awards of 6,282 shares on March 2 and 5,799 shares on March 3, both at a price of $0.00 per share, reflecting vesting of performance-based restricted stock units tied to company metrics. He then executed issuer-mandated open-market sales of 1,550 shares at $49.72 on March 3 and 7,157 shares at a weighted average price of $49.75 on March 4 to cover tax withholding obligations upon vesting. After these transactions, he directly held 59,602 shares of Q2 Holdings common stock.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Financial Officer Jonathan Price reported a mix of stock awards and tax-related sales of common stock. He received 23,556 shares on March 2, 2026 and 21,746 shares on March 3, 2026 at no cost from performance-based restricted stock units that vested.

To cover tax withholding tied to these vestings, he executed issuer-mandated open-market sales of 7,680 shares on March 3, 2026 at about $49.72 per share and 32,156 shares on March 4, 2026 at a weighted average price around $49.75 within a $49.75–$50.05 range. After these transactions, he directly held 197,135 shares of Q2 Holdings common stock.

Rhea-AI Summary

Q2 Holdings, Inc. Chief People Officer Kimberly Anne Rutledge reported multiple equity compensation events in common stock. She acquired 15,704 and 14,498 shares at no cost through grants tied to the final vesting of performance-based restricted stock units originally granted on March 2, 2023, based on company performance metrics described in her grant agreements.

Rutledge also executed open-market sales of 19,924 shares at a weighted average price of $49.75 per share and 3,905 shares at a weighted average price of $49.72 per share. A footnote states one sale was mandated by the issuer solely to cover tax withholding obligations related to restricted stock unit vesting and was not a discretionary trade, with trades executed in a price range from $49.75 to $50.05.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Executive Officer Matthew P. Flake reported a mix of stock awards and sales of the company’s common stock. He acquired 71,058 and 65,602 shares at no cost through performance-based restricted stock units that vested based on Q2’s financial and stock-price performance conditions set in prior grant agreements.

Flake then executed open-market sales of 91,590 shares at $49.75 per share and 26,921 shares at $49.72 per share. According to a footnote, one sale was mandated by the issuer to cover tax withholding tied to restricted stock unit vesting rather than a discretionary trade. After these transactions, he directly holds 503,815 shares.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Business Officer Kirk L. Coleman sold 12,917 shares of common stock in an open-market transaction at a weighted average price of $52.48 per share. The transaction was executed under a Rule 10b5-1 trading plan adopted on November 17, 2025.

After this sale, Coleman directly holds 256,211 Q2 Holdings shares. The shares were sold in multiple trades at prices ranging from $51.73 to $53.74, according to the disclosure.

Rhea-AI Summary

Q2 Holdings, Inc. Chief Revenue Officer reported two stock sales of company shares. On December 10, 2025, the insider sold 4,177 shares of common stock at a price of $73.68 per share, leaving 171,635 shares beneficially owned afterward. On December 12, 2025, the insider sold an additional 5,123 shares at a weighted average price of $75.46, with 166,512 shares beneficially owned following this transaction.

The filing explains that the first sale was an issuer-mandated sale to cover tax withholding tied to vesting of restricted stock units, rather than a discretionary trade. The second sale was executed under a pre-established Rule 10b5-1 trading plan adopted on June 13, 2024, which is designed to allow insiders to systematically sell shares under preset conditions.

Rhea-AI Summary

Q2 Holdings, Inc. reported an insider transaction by its Chief Operating Officer on Form 4. On 12/10/2025, the COO sold 3,024 shares of Q2 Holdings common stock at a price of $73.68 per share. According to the explanation, this was an issuer-mandated sale to cover tax withholding obligations tied to the vesting and settlement of Restricted Stock Units, so it was not a discretionary trade by the executive. After this transaction, the COO directly held 96,046 shares of Q2 Holdings common stock.

Rhea-AI Summary

Q2 Holdings, Inc. reported an insider transaction by its Chief Business Officer. On 12/10/2025, the executive sold 8,559 shares of Q2 Holdings common stock at a price of $73.68 per share. The filing explains that this sale was mandated by the company to cover tax withholding obligations related to the vesting and settlement of restricted stock units, meaning it was not a discretionary trade initiated by the executive. After this tax-related sale, the officer beneficially owned 269,128 shares of Q2 Holdings common stock in direct ownership.

Rhea-AI Summary

Q2 Holdings, Inc. (QTWO) director reports stock sale under pre-set plan. A company director filed a Form 4 showing the sale of 794 shares of Q2 Holdings common stock on 11/25/2025 at a price of $70.84 per share, coded as a sale transaction ("S").

After this transaction, the director beneficially owns 16,998 shares of Q2 Holdings common stock in direct ownership form. The filing notes that the sale was executed pursuant to a Rule 10b5-1 trading plan adopted on May 13, 2025, indicating the trades were made under a pre-arranged plan rather than discretionary market timing.